Selling cosmetics in the European Union is a product-control process, not simply a sales-channel decision. Before a finished cosmetic product is first placed on the EU market, the business needs to confirm the product classification, appoint an EU-established Responsible Person, prepare the Product Information File (PIF) and cosmetic product safety report (CPSR), review the formula and label, and complete the required Cosmetic Products Notification Portal (CPNP) notification.
This practical guide explains a sensible market-entry sequence for brands, importers, distributors, and contract-manufacturing teams. It is general educational information, not legal advice or a substitute for a product-specific regulatory assessment.
Start by confirming that the product is a cosmetic
Regulation (EC) No 1223/2009 is the main EU framework for finished cosmetic products placed on the Union market. Under Article 2, a cosmetic product is intended to contact external parts of the human body, teeth, or oral mucous membranes mainly to clean, perfume, change appearance, protect, keep in good condition, or correct body odours.
Check classification using the finished product as sold: formula, intended use, product name, directions, label, website copy, marketplace listing, images, and advertising claims. A formula that can be used in a cosmetic context may still need a different regulatory analysis if its presentation or claims suggest a medicinal, biocidal, or other regulated function.
The market-entry structure at a glance
| Market-entry element | EU requirement | Who normally owns it |
|---|---|---|
| Responsible Person | An EU-established natural or legal person must be designated for a cosmetic product placed on the market. | EU brand entity, importer, or an appointed specialist provider. |
| Safety and product file | Maintain the CPSR and PIF at the Responsible Person’s address and keep it accessible to competent authorities. | Responsible Person with evidence from the brand and manufacturer. |
| CPNP notification | Submit the prescribed product information before the product is placed on the EU market. | Responsible Person; distributors have duties in specified cases. |
| Market controls | Keep composition, labelling, claims, traceability, and post-market actions aligned with the Regulation. | Brand, manufacturer, importer, Responsible Person, and distributor. |
1. Appoint the Responsible Person before launch
Article 4 makes the Responsible Person (RP) the compliance anchor. Only cosmetic products for which a legal or natural person is designated within the EU as RP can be placed on the market. The RP must have real access to the current product record, rather than being named only in a commercial agreement.
For products manufactured outside the EU, agree early who will be the importer and who will act as RP. Confirm the RP’s name and address for label release, establish document-access responsibilities, and define how formula or packaging changes will be communicated. A change to the formula, fragrance, supplier, concentration, claims, intended user, packaging, or label may require an updated safety and compliance review.
2. Build the PIF and complete the CPSR
Article 11 requires a PIF for every cosmetic product. The file must be kept for ten years after the date the last batch was placed on the market and be readily accessible at the RP’s address. The PIF includes a product description, the CPSR, a description of the manufacturing method and a good-manufacturing-practice statement, evidence supporting claims where appropriate, and relevant animal-testing data.
The CPSR is the product safety assessment required under Article 10 and Annex I. It should be based on a controlled version of the finished formula, relevant raw-material information, impurities and exposure data, packaging considerations, product category, instructions, and intended use. Do not treat an ingredient list or a supplier declaration as a substitute for a product-level safety assessment.
| Launch record | Practical control | Evidence to retain |
|---|---|---|
| Product identity | Lock the product name, category, variants, intended use, and final formula version. | Formula specification, variant matrix, artwork-release record. |
| Safety and PIF | Complete the CPSR and assemble the Article 11 PIF before market placement. | Signed CPSR, assessor details, technical data package, PIF index. |
| Manufacturing quality | Apply Article 8 GMP controls; EN ISO 22716 is the harmonised GMP standard identified by the Commission. | Batch record, quality procedures, supplier controls, deviation and change-control records. |
| Formula restrictions | Review the finished formula against the applicable Annex conditions, including prohibited or restricted substances, colorants, preservatives, and UV filters. | Formula review, raw-material specifications, concentration and warning assessment. |
| Notification and label release | Notify through CPNP before market placement and release only reviewed labelling and claims. | CPNP record, approved label artwork, language and claims review. |
3. Apply GMP and composition controls
Article 3 requires cosmetic products to be safe for human health under normal or reasonably foreseeable conditions of use. Article 8 requires manufacture in compliance with good manufacturing practice. The European Commission identifies EN ISO 22716:2007 as the harmonised GMP standard associated with the cosmetics framework.
Formula compliance needs to be assessed in the context of the finished product. Review concentration, product category, conditions of use, warnings, impurities, exposure route, and all applicable Annex limits. Use the Commission’s CosIng resource as a reference point for ingredient information and regulatory status, but maintain a product-specific assessment and current source records.
4. Prepare labels and claims for the member state of sale
Article 19 specifies labelling particulars. The label must be reviewed along with the outer packaging, product page, marketplaces, social assets, and retail materials. National language requirements can apply where the product is made available, so plan translations as controlled compliance outputs rather than after-launch marketing work.
Article 20 prevents claims that imply a product has characteristics or functions it does not have. Substantiation should be proportionate to the claim and retained in the PIF where required. Avoid turning cosmetic claims into medical or therapeutic promises through product names, before-and-after imagery, advertising, or instructions.
5. Notify in the CPNP before placing the product on the market
Article 13 requires Responsible Persons and, in certain circumstances, distributors to submit prescribed information via the CPNP before products are placed or made available on the EU market. CPNP is a free EU-level notification system; after notification, no further national notification is required within the EU. Notification does not replace the underlying duties for safety, PIF, label, claims, and post-market control.
Products containing nanomaterials may require additional attention. The Commission describes an Article 16 CPNP module for products containing nanomaterials, in addition to the Article 13 notification. Identify any potential nanomaterial status early enough to resolve data and timing requirements before commercial launch.
6. Establish traceability and post-market response
Launch readiness should include batch traceability, a complaint and adverse-event route, contact details for the RP, a change-control process, and a documented pathway for corrective action. The Commission notes that EU countries conduct market surveillance and that serious undesirable effects must be reported to the relevant national authorities. If product evidence, claims, labelling, or safety information changes, reassess the product record before continuing distribution.
Launch checklist for EU cosmetic sales
- Confirm that the finished product and all commercial presentation fit the cosmetic-product definition.
- Designate an EU-established Responsible Person and document access to the product file.
- Freeze the formula and compile the information needed for the CPSR.
- Complete the CPSR and maintain the PIF at the RP address.
- Verify GMP controls and review the formula against current Annex conditions.
- Approve the final packaging, ingredients list, warnings, claims, and relevant national-language versions.
- Submit the Article 13 CPNP notification before market placement; assess Article 16 needs for nanomaterials.
- Release controlled listings and marketing assets, then maintain complaint, vigilance, and change-control procedures.
For an overview of the Regulation’s core operating requirements, see MOOYAM’s EU Cosmetics Regulation 1223/2009 guide.
Official sources
- EUR-Lex: Regulation (EC) No 1223/2009 on cosmetic products
- European Commission: Cosmetics legislation
- European Commission: Cosmetic Product Notification Portal
- European Commission: Cosmetics
- European Commission: Cosmetics market surveillance
- European Commission: Nanomaterials in cosmetics
Compliance disclaimer: This article provides general educational information, not legal advice. Requirements for a specific cosmetic product depend on its formula, intended use, claims, labelling, supply chain, and the current consolidated legislation. Obtain qualified EU regulatory advice before placing a product on the market.